|
|
|
|
|
|
Vascular Biogen. Ord (VBLT)
|
|
5.80 -0.30 (-4.92%)
|
10/16/2017 4:00pm
|
|
Open:
|
6.15
|
Pre. Close:
|
6.10
|
|
High:
|
6.15
|
Low:
|
5.80
|
|
Volume:
|
260,537
|
Market Cap:
|
156.65M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
6.15 - 6.43
|
6.43 - 6.49
|
|
Low:
|
5.34 - 5.63
|
5.63 - 5.69
|
|
Close:
|
5.45 - 5.9
|
5.9 - 5.98
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-16 4:49:36 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 7.49 One year: 8.47
|
|
Support:
|
Support1: 5.07 Support2: 4.22
|
|
Resistance:
|
Resistance1:
6.42 Resistance2: 7.25
|
|
Pivot:
|
6.02
|
|
Moving Averages:
|
MA(5): 6.13 MA(20): 6.17
MA(100): 5.04  MA(250): 5.23
|
|
MACD:
|
MACD(12,26):
0.16 Signal(12,26,9): 0.22
|
|
%K %D:
|
%K(14,3): 28.74 %D(3): 37.97
|
|
RSI:
|
RSI(14): 48.74
|
|
52-Week:
|
High: 7.25
Low: 3.90 Change(%): 16.0
|
|
Average Vol(K):
|
3-Month: 15525
10-Days 12669
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.VBLT has closed above bottom band by 16.9%. Bollinger Bands are 37.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Fri, 08 Sep 2017 14:57:09 GMT
Brokerages Set Vascular Biogenics Ltd. (VBLT) Target Price at $14.75
Sat, 06 May 2017 10:41:15 GMT
Vascular Biogenics: Initiating Coverage With First Price Target Of $13
Mon, 15 May 2017 15:45:00 GMT
Vascular Biogenics' (VBLT) CEO Dror Harats on Q1 2017 Results - Earnings Call ...
Mon, 14 Aug 2017 16:07:30 GMT
Vascular Biogenics' (VBLT) CEO Dror Harats on Q2 2017 Results - Earnings Call ...
Thu, 25 May 2017 18:56:15 GMT
Vascular Biogenics: An Under-The-Radar Oncology Play Near $6
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
